Synopsis: Fabtech Technologies had a strong performance for the quarter that ended in March 2026, with consolidated net profit increasing by over 46%. This solid quarterly growth led to a double-digit rise in its stock price, outperforming the broader Nifty IPO index.
For the fourth quarter that ended in March 2026, Fabtech Technologies Limited reported a significant 46.19% increase in consolidated net profit, reaching Rs. 22.06 crore, compared to Rs. 15.09 crore in the same period last year.
Revenue from operations for the quarter rose 17.54% to Rs. 158.52 crore. The company also improved its operational efficiency, with its Operating Profit Margin (OPM) increasing to 14.01%, up from 13.61% in the same quarter last year.
On a full-year basis, the company showed strong scalability, with annual sales rising 25.74% to Rs. 410.77 crore. While annual net profit fell by 17.42% to Rs. 38.36 crore, mainly due to a high base effect and particular cost changes in earlier quarters, the strong recovery in the March quarter indicates solid momentum heading into the new fiscal year. The company’s Profit Before Tax (PBT) for the quarter was Rs. 29.89 crore, reflecting a healthy growth of 50%.
Investors responded enthusiastically to the earnings report during the early trading session on April 28, 2026. Fabtech Technologies shares jumped 12.6%, reaching a high of Rs. 182.79, significantly outperforming the nearly flat Nifty 50. The stock reached an intraday high of Rs. 182.79, backed by strong buy-side demand of over 61.41% in the order book. Trading volume was notably high, with 38.08 lakh shares traded in the first hour, amounting to Rs. 67.66 crore in value.
The stock has shown impressive short-term performance, gaining 10.89% over the last week and about 12.89% over the past month. With a market capitalization over Rs. 750 crore, the company is trading well above its recent 52-week low of Rs. 132.70. The deliverable quantity of over 26.53% indicates strong confidence among long-term investors following the earnings report.
About the Company
Fabtech Technologies Limited, listed in October 2025, is a key player in the Medical Equipment and Supplies industry. The company focuses on providing complete engineering solutions and infrastructure for global pharmaceutical and healthcare markets. Its expertise includes the design, installation, and commissioning of cleanroom environments and specialized pharmaceutical machinery, making it an important partner in the global healthcare manufacturing ecosystem.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
